Induced pluripotent stem cells: how they will change the practice of cardiovascular medicine

Wing T.ak Wong, Nazish Sayed, John P. Cooke

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Induced pluripotent stem cells (iPSCs) can be generated from adult somatic tissues by the forced expression of a few defined transcription factors, including Oct4, Sox2, Klf4, and c-Myc. iPSC technology holds tremendous promises for therapeutic cardiovascular regeneration because of the cells' unlimited capacity for proliferation and differentiation into all cell lineages. The iPSCs can be generated from somatic cells of patients with a genetic basis for their disease so as to understand the pathobiology of the disorder. This disease modeling can be adapted to high-throughput screens to discover new therapeutic molecules. Finally, the iPSC technology may enable personalized cell therapies, while avoiding the ethical concerns surrounding human embryonic stem cells. Intensive efforts are underway to develop reliable methods to guide stem cell differentiation into cardiovascular lineages in the treatment of peripheral artery disease and heart diseases. Studies of disease pathogenesis and drug discovery using iPSC technology shall advance the discovery of novel treatments for cardiovascular diseases.

Original languageEnglish (US)
Pages (from-to)206-209
Number of pages4
JournalMethodist DeBakey cardiovascular journal
Issue number4
StatePublished - 2013


  • cardiovascular regeneration
  • disease modeling
  • induced pluripotent stem cells

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Induced pluripotent stem cells: how they will change the practice of cardiovascular medicine'. Together they form a unique fingerprint.

Cite this